Supreme Court Holds Over Two Patent Cases, Considers Two More on Patent Eligibility
Patently-O
MAY 1, 2023
Among the three patent cases considered, the court denied certiorari for the pro se case of Wakefield v. Teva Pharmaceuticals USA, Inc. 22-37: This case examines whether FDA-required labeling in a “skinny-label” situation can be considered patent infringement. Fall Line Patents, LLC v. Travel Sentry, Inc.,
Let's personalize your content